Xencor, Inc Operating Lease, Weighted Average Discount Rate, Percent
Xencor, Inc (XNCR) had Operating Lease, Weighted Average Discount Rate, Percent of 7.00% as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-05
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 7.00%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 7.00%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 7.00%.
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 7.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 7.00% 10-Q · filed 2026-08-05 |
| 2026-03-31 | 7.00% 10-Q · filed 2026-05-06 |
| 2025-12-31 | 7.00% 10-K · filed 2026-02-25 |
| 2025-09-30 | 7.00% 10-Q · filed 2025-11-05 |
| 2025-06-30 | 7.00% 10-Q · filed 2026-08-05 |
| 2025-03-31 | 7.00% 10-Q · filed 2026-05-06 |
| 2024-12-31 | 7.00% 10-K · filed 2026-02-25 |
| 2024-09-30 | 7.00% 10-Q · filed 2025-11-05 |
| 2024-06-30 | 7.00% 10-Q · filed 2025-08-06 |
| 2024-03-31 | 7.00% 10-Q · filed 2025-05-07 |
| 2023-12-31 | 8.90% 10-K · filed 2025-02-27 |
| 2023-09-30 | 8.80% 10-Q/A · filed 2025-02-24 |
| 2023-06-30 | 8.90% 10-Q/A · filed 2025-02-24 |
| 2023-03-31 | 8.90% 10-Q/A · filed 2025-02-24 |
| 2022-12-31 | 8.90% 10-K · filed 2025-02-27 |
| 2022-09-30 | 9.10% 10-Q · filed 2023-11-08 |
| 2022-06-30 | 6.00% 10-Q · filed 2023-08-03 |
| 2022-03-31 | 5.80% 10-Q · filed 2023-05-08 |
| 2021-12-31 | 5.80% 10-K/A · filed 2025-02-24 |
| 2021-09-30 | 5.70% 10-Q · filed 2022-11-07 |
| 2021-06-30 | 4.00% 10-Q · filed 2022-08-03 |
| 2021-03-31 | 5.50% 10-Q · filed 2022-05-05 |
| 2020-12-31 | 5.50% 10-K · filed 2023-02-27 |
| 2020-09-30 | 5.50% 10-Q · filed 2021-11-08 |
| 2020-06-30 | 5.50% 10-Q · filed 2020-08-05 |
| 2020-03-31 | 5.50% 10-Q · filed 2020-05-08 |
| 2019-12-31 | 5.50% 10-K · filed 2022-02-24 |
| 2019-09-30 | 5.50% 10-Q · filed 2019-11-05 |
| 2019-06-30 | 5.50% 10-Q · filed 2019-08-07 |
| 2019-03-31 | 5.50% 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |